AzTrials
AzTrials

Nonvital ToothNCT07508475

Clinical Assessment of CAD/CAM Fabricated Lithium-Disilicate Overlay Versus Lithium-disilicate Endocrowns for Restoration of Endodontically Treated Teeth.

A study testing lithium disilicate overlays in people with Nonvital Tooth, run by Cairo University at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

A Randomized Controlled Clinical Study aims for Clinical Assessment of CAD/CAM Fabricated Lithium-Disilicate overlay in comparison to Lithium-disilicate Endocrowns for Restoration of Endodontically Treated Teeth. Read more about this study

Who is it for?
Ages 18 to 60 yearsHealthy volunteers can take part
Conditions the study is for
Nonvital Tooth
What is being tested?
lithium disilicate overlays
Could I receive a placebo?
No, everyone receives an active treatment
How many people
25 participants
Where
1 siteEgypt
Study dates
1 Aug 2023to 15 Mar 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 60 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Patients with endodontically treated teeth indicated to ceramic Endocrowns.
  • Patients with endodontically treated teeth indicated to ceramic overlays.
  • Physically and psychologically able to tolerate conventional restorative procedures.
  • Have no active periodontal or periapical diseases.
  • Maintenance of good oral hygiene.
  • Willing to return for follow-up examinations and evaluation.

Who cannot join

  • Patients in the growth stage with partially erupted teeth.
  • Patients with para-functional habits.
  • Patients with defective endodontic treatment.
  • Patients with poor oral hygiene and motivation.
  • Psychiatric problems or unrealistic expectations.

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Faculty of Dentistry Cairo University

    Cairo, Cairo Governorate, 12567

Other trials in Egypt

About this study

Official title: Clinical Assessment of CAD/CAM Fabricated Lithium-Disilicate Overlay Versus Lithium-disilicate Endocrowns for Restoration of Endodontically Treated Teeth. A Randomized Controlled Clinical Study

A Randomized Controlled Clinical Study aims for Clinical Assessment of CAD/CAM Fabricated Lithium-Disilicate overlay in comparison to Lithium-disilicate Endocrowns for Restoration of Endodontically Treated Teeth.

Read the detailed description

Investigators are going to compare the clinical behavior of the lithium disilicate overlay as a more conservative line of treatment for endodontic treated teeth. overlays will be compared to the lithium disilicate endocrowns .primary outcome will be marginal adaptation ,secondary outcomes will be survival and patient satisfaction . Baseline, 5, 10, 15, and 20 months follow up will extend to 20 months(Baseline, 5, 10, 15, and 20 months) .This is a randomized, controlled, parallel-group clinical trial with 1:1 allocation ratio.

Conditions
Nonvital Tooth
Being tested
lithium disilicate overlays
Keywords
Nonvital, Overlay, Endocrown, Ceramics
Medical subject headings
Tooth, Nonvital

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • lithium disilicate overlaysOther

    Also called occlusal veneer ,ceramic partial coverage

    indirect partial coverage restoration that cover mainly the occlusal surface of posterior teeth

Study groups in NCT07508475
Study groupRoleWhat they receive
lithium disilicate endocrownActive comparatorNot described
Receives: Other: lithium disilicate overlays
overlayActive comparatorNot described
Receives: Other: lithium disilicate overlays

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. marginal adaptations

    Marginal adaptation will be evaluated using Modified United States Public Health Service (USPHS) criteria by two calibrated independent examiners. Scores will be recorded as Alpha, Bravo, or Charlie based on marginal integrity.

    Measured: Baseline, 5 months, 10 months, 15 months, and 20 months

Secondary outcomes (2)
  1. marginal discoloration

    change in margins colour as a result of leakage , Assessed using Modified USPHS criteria as Alpha, Bravo, or Charlie scores.

    Measured: Baseline, 5, 10, 15, and 20 months

  2. patient satisfaction

    patient acceptance to the treatment

    Measured: 20 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Apr 2026
  2. Study start1 Aug 2023
  3. Primary completion1 Mar 2024
  4. Study completion15 Mar 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
25 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07508475
Sponsor's protocol ID
Theme 3,Objective FPD 3-2-2
Status last verified
Mar 2026
First submitted
9 Mar 2026
Last updated
2 Apr 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing lithium disilicate overlays in people with Nonvital Tooth, run by Cairo University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 2 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

marginal adaptations (time frame: Baseline, 5 months, 10 months, 15 months, and 20 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Apr 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in